Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China
· Delayed Price · Currency is CNY 83.01
+0.02 (0.02%)
Feb 28, 2025, 2:44 PM CST
Xiamen Amoytop Biotech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Net Income | - | 555.45 | 287.02 | 181.2 | 116.57 | Upgrade
|
| Depreciation & Amortization | - | 57.56 | 48.07 | 43.15 | 38.17 | Upgrade
|
| Other Amortization | - | 10.66 | 2.3 | 1.18 | 0.64 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.87 | -0.03 | 1.8 | 1.13 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 12.76 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -6.2 | -3.92 | -6.78 | -4.84 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 0.35 | -1.41 | -2.34 | -0.19 | Upgrade
|
| Other Operating Activities | - | 1.72 | 0.59 | 1.58 | 2.8 | Upgrade
|
| Change in Accounts Receivable | - | -205.76 | -15.51 | -24.54 | -42.42 | Upgrade
|
| Change in Inventory | - | -57.29 | -13.24 | -16.87 | -29.02 | Upgrade
|
| Change in Accounts Payable | - | 153.19 | 61.89 | 63.92 | 9.69 | Upgrade
|
| Operating Cash Flow | - | 512.1 | 363.16 | 234.78 | 92.61 | Upgrade
|
| Operating Cash Flow Growth | - | 41.01% | 54.68% | 153.52% | -24.89% | Upgrade
|
| Capital Expenditures | - | -288.46 | -219.17 | -190.93 | -118.81 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.04 | 0.11 | 0.34 | 0.06 | Upgrade
|
| Investment in Securities | - | -17.35 | -70.34 | 78.66 | -264.18 | Upgrade
|
| Other Investing Activities | - | - | - | 0.09 | 0.94 | Upgrade
|
| Investing Cash Flow | - | -305.76 | -289.4 | -111.84 | -381.99 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 10 | 18.92 | Upgrade
|
| Total Debt Issued | - | - | - | 10 | 18.92 | Upgrade
|
| Short-Term Debt Repaid | - | - | -10 | -18.92 | -60 | Upgrade
|
| Long-Term Debt Repaid | - | -6.26 | -7.69 | -4.61 | - | Upgrade
|
| Total Debt Repaid | - | -6.26 | -17.69 | -23.53 | -60 | Upgrade
|
| Net Debt Issued (Repaid) | - | -6.26 | -17.69 | -13.53 | -41.08 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 348.16 | Upgrade
|
| Common Dividends Paid | - | -86.65 | -40.68 | -20.68 | -12.72 | Upgrade
|
| Other Financing Activities | - | - | - | - | -13.24 | Upgrade
|
| Financing Cash Flow | - | -92.91 | -58.37 | -34.2 | 281.11 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -1.11 | 0.03 | -0.49 | -0.96 | Upgrade
|
| Net Cash Flow | - | 112.32 | 15.42 | 88.25 | -9.23 | Upgrade
|
| Free Cash Flow | - | 223.64 | 143.99 | 43.85 | -26.2 | Upgrade
|
| Free Cash Flow Growth | - | 55.31% | 228.34% | - | - | Upgrade
|
| Free Cash Flow Margin | - | 10.65% | 9.43% | 3.87% | -3.30% | Upgrade
|
| Free Cash Flow Per Share | - | 0.55 | 0.36 | 0.11 | -0.07 | Upgrade
|
| Cash Income Tax Paid | - | 168.12 | 112.85 | 71.33 | 63.82 | Upgrade
|
| Levered Free Cash Flow | - | 41.08 | 127.17 | 11.47 | -64.97 | Upgrade
|
| Unlevered Free Cash Flow | - | 41.4 | 127.56 | 12.14 | -63.43 | Upgrade
|
| Change in Net Working Capital | - | 150.78 | -71.31 | -20.21 | 62.72 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.